EntryPoint Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,245
Closed -$92K 1166
2024
Q2
$92K Sell
4,245
-5,943
-58% -$125K 0.13% 347
2024
Q1
$226K Buy
10,188
+6,244
+158% +$152K 0.2% 83
2023
Q4
$108K Buy
+3,944
New +$95.2K 0.1% 342

Other funds holding VCYT

EntryPoint Capital's VCYT Position: Q3 2024 in Review

EntryPoint Capital sold out of Veracyte (VCYT) in Q3 2024, closing a stake of 4,245 shares — an estimated $92K sold.

EntryPoint Capital first reported a position in VCYT in Q4 2023 and held it in 3 quarters. The position peaked at $226K in Q1 2024. 293 funds tracked by Wall St. Rank hold VCYT as of Q3 2024.

  • EntryPoint Capital reported no remaining Veracyte position as of Q3 2024 after selling out during the quarter.
  • EntryPoint Capital sold 4,245 Veracyte shares in Q3 2024, an estimated $92K.
  • EntryPoint Capital first reported a position in Veracyte in Q4 2023 and held it in 3 quarters.
  • EntryPoint Capital's Veracyte position peaked at $226K in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Veracyte as of Q3 2024.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.